Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0A9WC
|
||||
| Former ID |
DNC012314
|
||||
| Drug Name |
PT-319
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [1] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C13H15N3OS2
|
||||
| Canonical SMILES |
COC1=CC=CC(=C1)CCNC(=S)NC2=NC=CS2
|
||||
| InChI |
1S/C13H15N3OS2/c1-17-11-4-2-3-10(9-11)5-6-14-12(18)16-13-15-7-8-19-13/h2-4,7-9H,5-6H2,1H3,(H2,14,15,16,18)
|
||||
| InChIKey |
TXUPZNCSUKFSFG-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | HIV-1 reverse transcriptase | Target Info | Inhibitor | [1] | |
| References | |||||
| REF 1 | J Med Chem. 1995 Dec 8;38(25):4929-36.Phenethylthiazolethiourea (PETT) compounds, a new class of HIV-1 reverse transcriptase inhibitors. 1. Synthesis and basic structure-activity relationship studiesof PETT analogs. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.